1. Home
  2. MYE vs KROS Comparison

MYE vs KROS Comparison

Compare MYE & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYE
  • KROS
  • Stock Information
  • Founded
  • MYE 1933
  • KROS 2015
  • Country
  • MYE United States
  • KROS United States
  • Employees
  • MYE N/A
  • KROS N/A
  • Industry
  • MYE Auto Parts:O.E.M.
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYE Consumer Discretionary
  • KROS Health Care
  • Exchange
  • MYE Nasdaq
  • KROS Nasdaq
  • Market Cap
  • MYE 547.3M
  • KROS 558.9M
  • IPO Year
  • MYE N/A
  • KROS 2020
  • Fundamental
  • Price
  • MYE $15.51
  • KROS $14.53
  • Analyst Decision
  • MYE Buy
  • KROS Buy
  • Analyst Count
  • MYE 1
  • KROS 13
  • Target Price
  • MYE $21.00
  • KROS $20.63
  • AVG Volume (30 Days)
  • MYE 260.9K
  • KROS 477.3K
  • Earning Date
  • MYE 07-31-2025
  • KROS 08-06-2025
  • Dividend Yield
  • MYE 3.50%
  • KROS N/A
  • EPS Growth
  • MYE N/A
  • KROS N/A
  • EPS
  • MYE 0.28
  • KROS 0.11
  • Revenue
  • MYE $835,929,000.00
  • KROS $214,713,000.00
  • Revenue This Year
  • MYE $1.16
  • KROS $5,006.76
  • Revenue Next Year
  • MYE $1.99
  • KROS N/A
  • P/E Ratio
  • MYE $55.14
  • KROS $132.80
  • Revenue Growth
  • MYE 3.92
  • KROS 91657.70
  • 52 Week Low
  • MYE $9.06
  • KROS $9.12
  • 52 Week High
  • MYE $17.39
  • KROS $72.37
  • Technical
  • Relative Strength Index (RSI)
  • MYE 68.36
  • KROS 64.67
  • Support Level
  • MYE $14.99
  • KROS $13.26
  • Resistance Level
  • MYE $15.57
  • KROS $14.68
  • Average True Range (ATR)
  • MYE 0.41
  • KROS 0.41
  • MACD
  • MYE -0.03
  • KROS 0.12
  • Stochastic Oscillator
  • MYE 85.31
  • KROS 89.35

About MYE Myers Industries Inc.

Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: